Paper39698574
Anti-cancer role of curcumin in prostate cancer cells via regulation of m6A-modified circ0030568-FMR1 signaling pathway.
Sun X and 6 others. Transl Androl Urol, 2024. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Anti-cancer role of curcumin in prostate cancer cells via regulation of m6A-modified circ0030568-FMR1 signaling pathway. Papers, record 39698574. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39698574
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Anti-cancer role of curcumin in prostate cancer cells via regulation of m6A-modified circ0030568-FMR1 signaling pathway.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24713629 | The dynamic epitranscriptome: N6-methyladenosine and gene expression control. | Nat Rev Mol Cell Biol | 2014 | https://conductscience.org/library/papers/24713629 | PubMed |
| 2 | 31410208 | HMGB1 Promotes Prostate Cancer Development and Metastasis by Interacting with Brahma-Related Gene 1 and Activating the Akt Signaling Pathway. | Theranostics | 2019 | https://conductscience.org/library/papers/31410208 | PubMed |
| 3 | 34820150 | Circular RNAs in prostate cancer: Biogenesis,biological functions, and clinical significance. | Mol Ther Nucleic Acids | 2021 | https://conductscience.org/library/papers/34820150 | PubMed |
| 4 | 35320754 | Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells. | Mol Cell | 2022 | https://conductscience.org/library/papers/35320754 | PubMed |
| 5 | 31277663 | Exosomal circRNAs: biogenesis, effect and application in human diseases. | Mol Cancer | 2019 | https://conductscience.org/library/papers/31277663 | PubMed |
| 6 | 31228940 | METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner. | Mol Cancer | 2019 | https://conductscience.org/library/papers/31228940 | PubMed |
| 7 | 34228629 | The Emerging Roles of RNA m6A Methylation and Demethylation as Critical Regulators of Tumorigenesis, Drug Sensitivity, and Resistance. | Cancer Res | 2021 | https://conductscience.org/library/papers/34228629 | PubMed |
| 8 | 39238004 | The multifaceted role of the stroma in the healthy prostate and prostate cancer. | J Transl Med | 2024 | https://conductscience.org/library/papers/39238004 | PubMed |
| 9 | 37200228 | Curcumin as a therapeutic agent in cancer therapy: Focusing on its modulatory effects on circular RNAs. | Phytother Res | 2023 | https://conductscience.org/library/papers/37200228 | PubMed |
| 10 | 35487055 | Human prostate cancer cell epithelial-to-mesenchymal transition as a novel target of arsenic trioxide and curcumin therapeutic approach. | Tissue Cell | 2022 | https://conductscience.org/library/papers/35487055 | PubMed |
| 11 | 31080453 | A Review in Research Progress Concerning m6A Methylation and Immunoregulation. | Front Immunol | 2019 | https://conductscience.org/library/papers/31080453 | PubMed |
| 12 | 33470439 | m6 A RNA methylation: from mechanisms to therapeutic potential. | EMBO J | 2021 | https://conductscience.org/library/papers/33470439 | PubMed |
| 13 | 19888222 | Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth. | Br J Cancer | 2009 | https://conductscience.org/library/papers/19888222 | PubMed |
| 14 | 34576132 | Growth, Proliferation and Metastasis of Prostate Cancer Cells Is Blocked by Low-Dose Curcumin in Combination with Light Irradiation. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34576132 | PubMed |
| 15 | 32366907 | YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation. | Oncogene | 2020 | https://conductscience.org/library/papers/32366907 | PubMed |
| 16 | 38230215 | n6-methyladenosine-modified circular RNA family with sequence similarity 126, member A affects cholesterol synthesis and malignant progression of prostate cancer cells by targeting microRNA-505-3p to mediate calnexin. | J Cancer | 2024 | https://conductscience.org/library/papers/38230215 | PubMed |
| 17 | 37296999 | Role of Natural and Synthetic Compounds in Modulating NRF2/KEAP1 Signaling Pathway in Prostate Cancer. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37296999 | PubMed |
| 18 | 29911069 | Circular RNAs in Cancer - Lessons Learned From microRNAs. | Front Oncol | 2018 | https://conductscience.org/library/papers/29911069 | PubMed |
| 19 | 37056926 | M6A-modified circRBM33 promotes prostate cancer progression via PDHA1-mediated mitochondrial respiration regulation and presents a potential target for ARSI therapy. | Int J Biol Sci | 2023 | https://conductscience.org/library/papers/37056926 | PubMed |
| 20 | 37541540 | Curcumin in cancer therapy: Exploring molecular mechanisms and overcoming clinical challenges. | Cancer Lett | 2023 | https://conductscience.org/library/papers/37541540 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42953404 | Metabolic control of methylation landscapes in cancer growth and plasticity: targeting the epigenetic-metabolic axis with natural compounds and emerging therapies. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42953404 | PubMed |
| 42373923 | The power of phytochemicals in cancer chemoprevention through multi-target modulation of oncogenic signaling pathways. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42373923 | PubMed |
| 41766860 | The emerging role of m6A methylation in prostate-related diseases: mechanisms and clinical implications. | Front Immunol | 2026 | https://conductscience.org/library/papers/41766860 | PubMed |
| 41446042 | RNA modifications in health and disease: from mechanistic insights to therapeutic applications. | Precis Clin Med | 2025 | https://conductscience.org/library/papers/41446042 | PubMed |
| 41322307 | Curcumin: biochemistry, pharmacology, advanced drug delivery systems, and its epigenetic role in combating cancer. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41322307 | PubMed |
| 41020838 | Revisiting Curcumin in Cancer Therapy: Recent Insights into Molecular Mechanisms, Nanoformulations, and Synergistic Combinations. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/41020838 | PubMed |
| 40760406 | Cancer-specific Regulation of Metabolic and Epigenetic Pathways by Dietary Phytochemicals. | Pharm Res | 2025 | https://conductscience.org/library/papers/40760406 | PubMed |
| 40016786 | Multiple roles of circular RNAs in prostate cancer: from the biological basis to potential clinical applications. | Eur J Med Res | 2025 | https://conductscience.org/library/papers/40016786 | PubMed |
| 40002385 | Antioxidant Senotherapy by Natural Compounds: A Beneficial Partner in Cancer Treatment. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40002385 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FMR1 | 2332 | PubTator's text mining | https://conductscience.org/library/genes/2332 | NCBI Gene |
| METTL3 | 56339 | PubTator's text mining | https://conductscience.org/library/genes/56339 | NCBI Gene |
| YTHDF2 | 51441 | PubTator's text mining | https://conductscience.org/library/genes/51441 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39698574
GET https://conductscience.org/api/papers/v1/39698574/references?page=2